Optimizing the Cas13 antiviral train: cargo and delivery
Abstract The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic in 2020 highlighted the need for rapid, widespread responses against infectious disease. One such innovation uses CRISPR‐Cas13 technology to directly target and cleave viral RNA, thereby inhibiting replication. Due to...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2023-05-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.202217146 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|